Senseonics (NYSE:SENS) announced today that it commenced an underwritten public offering of common stock worth $50 million.

Abbott today announced results from real-world studies demonstrating benefits with its FreeStyle Libre CGM technology.

Embecta now expects revenues between $1.073 billion and $1.09 billion. This would mark a sales dip of between 4.4% and 2.9% ...

Phillips Medisize announced that it officially integrated Vectura into its business, expanding its capabilities in inhaled ...

Medtronic (NYSE:MDT) announced today that it appointed Kate Cronin as the new chief marketing officer for its Diabetes unit.

Dexcom (Nadsaq:DXCM) shares rose after hours today on first-quarter results that came in mixed compared to the consensus ...

Beta Bionics (Nasdaq:BBNX) shares remained unmoved after hours today on first-quarter results that topped the consensus sales ...

Dexcom (Nasdaq:DXCM) announced today that it promoted Jake Leach to the role of president, in addition to his post as COO.

Glucotrack (Nasdaq:GCTK) announced today that it received a hospital's ethical approval to study its continuous blood glucose ...

BD (NYSE:BDX) filed a lawsuit in a U.S. District Court alleging patent infringement by Baxter (NYSE:BAX) related to infusion ...

Roche announced today that it plans to invest up to $550 million to expand its continuous glucose monitoring (CGM) site in ...

Insulet recorded a 31.3% bottom-line slide on a sales increase of 28.8%. Adjusted to exclude one-time items, earnings per ...